The Ingredients Banned in Mexico Your Formulator Doesn't Know About

What you actually need to know before shipping supplements to Mexico

You built a compliant supplement brand in the US. CoA documents, FDA facility registration, third-party testing, a label your attorney signed off on. You've seen the AMVO numbers. Mexico's ecommerce market is worth $43–55 billion according to AMVO's 2024 report. Spanish-speaking consumers are already finding you organically. So you figure: same formula, translate the label, ship it.

Here's what that assumption costs you: it blows up after packaging is printed, inventory is staged, and ad budget is allocated. Not before. After.

Mexico's supplement regulatory system isn't a looser version of the US system. It's a completely different one.(https://www.gob.mx/cofepris). Mexico's FDA equivalent. controls how supplements are classified, which ingredients are permitted, what claims can appear on a label, and what documentation must exist before a product legally enters the country. Some ingredients that are unrestricted in the US are banned or dose-capped in Mexico's suplemento alimenticio category. Some ordinary wellness language from your US label will reclassify your product as a medicamento, which triggers an entirely different and far more demanding approval track.

The founders I've seen get hurt on this aren't reckless. They're experienced operators who assumed a category-legal product in the US would be category-legal in Mexico. That assumption is wrong, and the further into production you get before finding out, the worse the bill.

---

How Mexico's supplement classification actually works

Classification first. Not before launch. before manufacturing.

Mexico draws hard lines between a suplemento alimenticio (dietary supplement), a medicamento herbolario (herbal medicine), and a remedio herbolario (herbal remedy). These aren't interchangeable buckets. Which one your product lands in depends on two things: what's in the formula, and how you describe what it does. We covered the full decision tree in the classification guide.

The claims issue catches US brands off guard more than anything else. If your label says the product "prevents inflammation," "relieves anxiety," or "supports immune function against pathogens". you've framed a supplement as a medicine. COFEPRIS doesn't just read the physical label. They look at your website and your ad copy too. One line of therapeutic language on your DTC product page can push your entire SKU into a regulatory category requiring clinical dossiers and formal registration before a single unit crosses the border.

This decision needs to happen before manufacturing. Once the formula is locked and the packaging is printed, reclassification costs you a reprint run and weeks of delay at minimum.

The ingredient audit is where most US formulas fail

After classification, you run every active ingredient against Mexico's prohibited and restricted lists. Based on COFEPRIS-aligned regulatory guidance, the following are problem ingredients for the suplemento alimenticio category:

• Hormones
• Ephedrine and similar stimulants
• Yohimbine
• Procaine
• Germanium
• Melatonin (restricted. not freely permitted as in the US)
• Caffeine above established dose thresholds
• Cannabis derivatives (CBD and related compounds are disallowed for nutraceuticals in Mexico)
• Pharmaceutical-grade or controlled substances
• Specific botanicals on Mexico's restricted plant annex

That list surprises almost every US supplement founder the first time they see it. Melatonin is at every US grocery checkout. CBD has been a multi-billion-dollar US category for years. Yohimbine is in half the pre-workouts on shelves right now. None of them are freely permitted in the Mexican supplement category. "Legal in the US" and "legal in the EU" do not carry over. We break down 7 specific products that hit this wall.

The audit isn't a formality. it's the one step where you find out whether your formula is viable for Mexico at all. Do it before production is locked, not after.

Labeling is a compliance project, not a translation project

Once you've confirmed your product qualifies as a supplement and your ingredients clear the audit, you build the Mexican label. The instinct is to take your US label and hand it to a translator. Don't. The output won't be compliant.

COFEPRIS-aligned labeling requirements include: full Spanish text on all panels; ingredients declared in descending quantitative order (the fórmula cuali-cuantitativa); nutrition facts in análisis bromatológico format per Mexican standards; NOM-051 and NOM-050 compliance for packaged food and supplement products; and no disease claims, curative claims, or language implying prevention or rehabilitation.

That last item is where US brands slip consistently. "Supports healthy sleep" is borderline. "Promotes immune defense" is borderline. "Helps your body recover faster" depends on what else is on the label. The safe position is claims that describe nutritional support with no therapeutic implication. Build the Mexican label from scratch against Mexican requirements. Then adapt your packaging around it.

Import clearance is its own gate. a separate one

Label is right. Formula cleared the audit. Classification is confirmed. You still can't just ship.

As Trade.gov's Mexico country commercial guide documents, restricted goods require prior permits or conditions from competent authorities, and product-specific import controls must be confirmed before shipment. For supplements, the derechos de importación and the pedimento aduanal aren't paperwork you handle on arrival. They're gating documents that need to be in order before inventory moves.

Brands that skip this have product sitting at customs, running up storage fees, waiting on documentation that should have been filed weeks earlier.

---

Costs and timeline: the part founders consistently underestimate

COFEPRIS review takes longer than you're planning for

COFEPRIS review for supplement classification, documentation review, and import authorization runs from several months to a year or more. Plan for six to twelve months from complete submission. and "complete" is doing a lot of work in that sentence.

The delay comes from two sources: the official review queue, and the fix-and-resubmit cycle that happens when the initial submission has errors or gaps. The queue you can't control. The fix-and-resubmit cycle is almost entirely preventable, and it's the one that actually kills launch dates.

Fix-and-resubmit is the real budget killer

Based on internal category data from Datahooks' brand tracking, Mexico entry budgets are most often blown on regulatory rework and last-mile import documentation. not on the initial filing fee.

The sequence looks like this: brand locks formula, prints packaging, submits documentation. COFEPRIS or the customs authority comes back with questions. Brand discovers a label element is non-compliant, or an ingredient needs additional documentation, or a claim needs to come off entirely. Brand reprints packaging. Resubmits. Timeline extends by weeks or months. Launch is delayed. Revenue target is missed.

This isn't an edge case. In Datahooks' data, it's the median experience for US brands that enter Mexico without Mexico-specific regulatory support. It ends up more expensive than a denied import, because by the time the denial happens, sourcing, packaging, and campaign assets are already built and paid for.

The support infrastructure cost is real and often invisible in the initial budget

Trade.gov explicitly flags customs regulations and product standards as a challenge for foreign brands entering Mexico. Legal counsel before entering any supplier or distributor agreements is not optional. Tax structure, RFC registration, eFirma (digital signature) setup, and ongoing CFDI invoicing compliance add operational overhead that US founders rarely budget for, because none of those categories exist in the US market context.

For brands in the $1M–$50M revenue range without in-house Mexico regulatory staff, working with a Mexico operations partner is often unavoidable. Tally Global, Datahooks' Mexico operations partner, handles entity setup, import-of-record function, and regulatory filing coordination. The cost of that support is real. So is the cost of not having it. it just shows up later, and in worse ways.

---

Common mistakes that cost founders real money

Mistake 1: assuming US supplement rules apply in Mexico

This is the foundational error, and experienced US operators make it just as often as first-timers. Their domestic compliance track record gives them false confidence. The DSHEA framework and Mexico's COFEPRIS suplemento alimenticio framework are not equivalent. A product that is fully category-legal under DSHEA may be category-illegal in Mexico because of a single ingredient, a dose threshold, or one claim. US compliance doesn't transfer. This pattern shows up across categories, not just supplements. The same assumptions cost food and beverage brands months.

Mistake 2: launching with banned or borderline ingredients

Melatonin. CBD. Yohimbine. Ephedrine. Caffeine above thresholds. These are commercially mainstream US supplement ingredients. They are not freely permitted in Mexico's supplement category. This check happens at formula audit, not at customs.

Mistake 3: disease-adjacent language anywhere in the marketing stack

"Cures," "prevents," "relieves," "rehabilitates". and their Spanish equivalents. can trigger reclassification from supplement to medicine. The risk isn't limited to the physical label. It includes your website, your Amazon MX listing copy, your MercadoLibre product description, and your paid social ads. COFEPRIS and customs authorities look at the full picture of how a product is presented.

Mistake 4: treating a Certificate of Free Sale as COFEPRIS clearance

A Certificate of Free Sale documents that a product is legally sold in the US. It says nothing about Mexico. COFEPRIS does not accept it as evidence of compliance with Mexican supplement regulations. These are different documents serving different purposes in different regulatory systems, and showing up at the Mexican border with only US documentation is an expensive way to learn that.

Mistake 5: finalizing production before confirming classification

The most expensive failure mode in Datahooks' category data is formula or label rework after sourcing, packaging, and campaign assets are already committed. Classification and ingredient audit go before manufacturing spend. not before launch, before manufacturing. Auditing a formula before production costs hours. Reprinting 50,000 units of packaging after a label rejection does not.

---

The compliance sequence, plain English

The order matters as much as the steps.

Reversing steps or skipping them doesn't compress the timeline. It creates rework that takes longer than doing it right the first time.

---

Next steps worth actually doing

Run the ingredient audit before anything else

Pull your full formula. every active ingredient, every botanical extract, every stimulant, every excipient that could be classified as an active component. Check each one against Mexico's prohibited substance list and restricted plant annexes. Pay attention to dose thresholds for vitamins and minerals, which Mexico caps differently than the US. The audit takes hours. The rework it prevents can take months.

Build the Mexico label before you touch the US one

Start from Mexican requirements: Spanish text, fórmula cuali-cuantitativa ordering, NOM-051 and NOM-050 format standards, claims reviewed for therapeutic language. Build the compliant Mexico label first. Then adapt the packaging around it.

Get classification confirmed by a Mexico regulatory specialist before production

This is not a DIY step. The line between suplemento alimenticio and medicamento herbolario can turn on ingredient context, dose levels, and claim language simultaneously. sometimes all three at once. A Mexico regulatory specialist who works with COFEPRIS classifications regularly can confirm your product's category before you commit production budget. The consultation cost is modest relative to a misclassification caught at customs.

Coordinate import documentation before the first shipment

For a test shipment, the T1 Exemption (courier importation) may apply for small-volume initial orders. For scaling to real import volume, you need an IOR (Importer of Record) in place and your pedimento aduanal structured correctly. These are not last-minute logistics details.

Build a realistic timeline into your launch plan

Count backward from your target sell date with a COFEPRIS review window of six to twelve months, plus time for ingredient audit, label build, and documentation filing. If the math doesn't work, move the launch date. The compliance steps don't compress because the calendar is tight.

Datahooks has built a Mexico Mexico Pilot Plan for US supplement and CPG brands at the $1M–$50M stage. It covers ingredient audit frameworks, classification decision trees, label compliance requirements, and import documentation sequencing. Access it at datahooks.ai/start, or book a call to walk through your specific formula and market entry scenario.

---

FAQ

Is my FDA-compliant supplement automatically legal to sell in Mexico?

No. US FDA compliance under DSHEA doesn't transfer. COFEPRIS runs a separate regulatory framework, and ingredients, dose levels, and claims that are legal under US rules may not be permissible under Mexico's suplemento alimenticio category. You need a Mexico-specific ingredient audit and classification review before assuming your product can be sold there.

What is COFEPRIS and why does it matter for supplements?

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is Mexico's federal health regulatory authority. It controls classification, labeling, import authorization, and market surveillance for supplements, food products, and medicines. It plays a role similar to the FDA, but with different rules, different ingredient lists, and different claim standards. Any US brand selling supplements in Mexico is operating under COFEPRIS jurisdiction.

Which ingredients are banned or restricted for supplements in Mexico?

The documented problem ingredients for the suplemento alimenticio category include melatonin, ephedrine, yohimbine, procaine, germanium, hormones, pharmaceutical-grade controlled substances, caffeine above established dose thresholds, cannabis derivatives including CBD, and specific botanicals on Mexico's restricted plant annex. This list isn't exhaustive. any formula intended for Mexico needs a full ingredient-by-ingredient audit against current COFEPRIS-aligned prohibited and restricted lists.

What happens if I ship product to Mexico without COFEPRIS clearance?

It gets held, returned, or seized at customs. You'll accumulate storage fees during any hold period. If the product is flagged as an unauthorized supplement or misclassified, it may be destroyed. Beyond the direct product loss, the documentation gap complicates any subsequent import attempt. The exposure from skipping clearance is consistently higher than the cost of doing it right.

How long does COFEPRIS review take for supplements?

Typically several months to a year or more, depending on formula complexity, submission completeness, and whether follow-up questions come back. Brands that submit incomplete documentation or need reclassification review see timelines extend significantly. Plan for at least six months from a complete submission and build buffer into your launch schedule.

Do I need a Mexican legal entity to sell supplements in Mexico?

For direct consumer sales and formal import at scale, yes. typically structured as an S. de R.L. de C.V. with an RFC (Registro Federal de Contribuyentes) tax ID registered with the(https://www.sat.gob.mx/). For initial test shipments under the T1 courier exemption, the threshold is lower. But if you're planning commercial volume, entity setup and tax registration are prerequisites, not afterthoughts.

Can I sell on Amazon Mexico or MercadoLibre without COFEPRIS clearance?

Both Amazon Mexico and MercadoLibre list supplements, and both require listed products to comply with applicable Mexican regulations. Selling on these platforms doesn't provide regulatory cover. A non-compliant product can be delisted, and customs enforcement applies to inventory flowing through fulfillment centers regardless of the sales channel. Platform compliance and COFEPRIS compliance are separate requirements.

What's the difference between a suplemento alimenticio and a medicamento herbolario?

A suplemento alimenticio provides nutritional support and makes no claim to treat, prevent, or rehabilitate anything. A medicamento herbolario is an herbal medicine with significantly higher regulatory requirements, including formal registration. The classification depends on both what's in the formula and how the product is positioned. and claims about preventing or treating conditions, even mild ones, can push a product across that line.

What does NOM labeling mean and which standards apply to supplements?

NOM (Norma Oficial Mexicana) standards are Mexico's official technical standards. For packaged food and supplement products, NOM-051-SCFI/SSA1-2010 covers labeling for packaged food and non-alcoholic beverages; NOM-050-SCFI-2004 covers general commercial information standards. Supplement labels must comply with both. The requirements specify text size, language, ingredient declaration order, and prohibited language. A label built to US FDA standards won't automatically meet NOM requirements.

What does Mexico market entry typically cost for a supplement brand?

There's no flat number, and anyone giving you one is guessing. Costs include regulatory consultation, label localization and compliance review, COFEPRIS filing fees, customs coordination, entity and RFC setup if not already in place, and ongoing operational infrastructure. The most consistently underestimated cost. based on Datahooks' internal category data. is regulatory rework after an initial filing comes back with questions. Budget for that scenario explicitly. The brands that don't are the ones that miss their launch dates by quarters, not weeks.

---

The Mexico opportunity is real. The $43–55 billion figure from AMVO isn't marketing fiction. But that number doesn't change what COFEPRIS requires, and it doesn't change what happens to inventory that crosses the border without proper documentation.

The brands that succeed in Mexico supplements did the ingredient audit before manufacturing, built the compliant label before printing, confirmed classification before committing production budget, and coordinated import documentation before the first shipment left the warehouse. A strong US compliance record doesn't shorten that list.

Start with the ingredient audit. Do it before production is locked. If you want a structured framework for it, the Datahooks Mexico Mexico Pilot Plan is at datahooks.ai/start.